Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 1,076–1,100 of 7,816 matching trials · page 44 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic Disorders NCT07573046 ExéSem cognitive battery Runs in: France · 1 site |
NA other |
NOT_YET_RECRUITING | 140 | Hospices Civils de Lyon OTHER |
2026-05-07 |
|
Ultrasonic Debris Clearance to Promote Brain Resilience NCT07573982 Ultrasonic Debris Clearance; sham Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 15 | Stanford University OTHER |
2026-05-07 |
|
Aβ Dynamics in LLMD NCT05004987 Escitalopram Oxalate; Placebo Runs in: United States · 2 sites |
PHASE4 other |
RECRUITING | 60 | NYU Langone Health OTHER |
2026-05-06 |
|
Coaching Dementia Caregivers to Master Care-Resistant Behavior NCT05098652 CuRB-IT Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 266 | University of Alabama at Birmingham OTHER |
2026-05-06 |
|
Music Therapy for Patients With Alzheimer's Disease NCT05151562 Virtual Music Therapy Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Johns Hopkins University OTHER |
2026-05-06 |
|
A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease NCT05476783 TB006 Runs in: United States · 13 sites |
PHASE2 other |
TERMINATED | 119 | TrueBinding, Inc. INDUSTRY |
2026-05-06 |
|
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study NCT05573490 Cognitive Training; Tai Chi- Qi Gong; Brain Games; Stretching Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Indiana University OTHER |
2026-05-06 |
|
Post-stroke Cognitive Impairment NCT05653141 Runs in: Switzerland · 1 site |
NA other |
RECRUITING | 600 | Roza Umarova OTHER |
2026-05-06 |
|
Gaze and Gait Training With rTMS NCT05864313 Repetitive Transcranial Magnetic Stimulation (rTMS); Gait training;... |
NA other |
NOT_YET_RECRUITING | 30 | University of Florida OTHER |
2026-05-06 |
|
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease NCT06538311 Active rTMS; Sham rTMS Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 30 | Massachusetts General Hospital OTHER |
2026-05-06 |
|
The Locus Coeruleus, Norepinephrine and Cognitive Aging NCT06880510 t-VNS transcutaneous auricular vagus nerve stimulator Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 150 | Cornell University OTHER |
2026-05-06 |
|
The Effect of Cognitive Telerehabilitation in Mild Cognitive Impairment NCT07042425 Computer based cognitive telerehabilitation Runs in: Indonesia · 1 site |
NA other |
COMPLETED | 36 | Universitas Padjadjaran OTHER |
2026-05-06 |
|
Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline NCT07044596 Functional near-infrared spectroscopy (fNIRS); V1 stimulation elect... Runs in: United States · 1 site |
NA other |
RECRUITING | 55 | University of Wisconsin, Madison OTHER |
2026-05-06 |
|
Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD NCT07499570 Smart Virtual Reminiscence Therapy; Music Therapy Runs in: United States · 1 site |
NA other |
RECRUITING | 60 | Indiana University OTHER |
2026-05-06 |
|
Community-based Screening for Alzheimer's Disease NCT07570719 No study-specific intervention Runs in: China · 4 sites |
NA other |
RECRUITING | 3,000 | Kuang XiaoJun OTHER |
2026-05-06 |
|
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases NCT02288000 Memantine; Placebo Runs in: France · 3 sites |
PHASE1 symptomatic-cholinergic |
TERMINATED | 30 | University Hospital, Lille OTHER |
2026-05-05 |
|
Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD NCT03461276 ABvac40; Placebo Runs in: France; Italy; Spain; Sweden · 23 sites |
PHASE2 other |
COMPLETED | 134 | Araclon Biotech S.L. INDUSTRY |
2026-05-05 |
|
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial NCT04588285 Ambroxol; Placebo Runs in: Norway · 8 sites |
PHASE2 other |
RECRUITING | 180 | Helse Fonna OTHER |
2026-05-05 |
|
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia NCT05386394 Active tDCS + Language Therapy; Sham tDCS + Language Therapy Runs in: Canada; United States · 3 sites |
PHASE2 other |
RECRUITING | 180 | Johns Hopkins University OTHER |
2026-05-05 |
|
δ in Dementia Clinical Trials NCT05592678 Donepezil Runs in: United States · 1 site |
NA symptomatic-cholinergic |
RECRUITING | 200 | The University of Texas Health Science Center at San Antonio OTHER |
2026-05-05 |
|
A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease NCT05681819 SHR-1707; SHR-1707 placebo Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 33 | Shanghai Hengrui Pharmaceutical Co., Ltd. INDUSTRY |
2026-05-05 |
|
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses NCT05877196 Moderate Intensity Continuous Training (MICT); Chair-based Stretch;... Runs in: United States · 1 site |
NA other |
RECRUITING | 216 | Arizona State University OTHER |
2026-05-05 |
|
A Digital Health App to Prevent Falls and Improve Well-being in People Living With Dementia NCT06149702 Combined intervention: Keep-on-Keep-Up-LITE (KOKU-LITE) programme a... Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 60 | Jaheeda Gangannagaripalli OTHER |
2026-05-05 |
|
Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50 NCT06338904 Problem-solving-based psychological intervention Runs in: Spain · 1 site |
NA other |
RECRUITING | 212 | University of Santiago de Compostela OTHER |
2026-05-05 |
|
Intranasal Oxytocin Intervention for Caregivers to Persons With Dementia NCT06364228 Placebo; Oxytocin Intranasal Spray 12 International Unit (12IU); Ox... Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 32 | University of Nebraska OTHER |
2026-05-05 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial